Clinical Trial Update: Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer

View source ↗

Summary

A clinical trial investigating whether neoadjuvant chemoradiotherapy can be omitted for patients with mid-rectal cancer (rectal cancer stage II–III); the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Turkish Society of Colon and Rectal Surgery | Conditions: Mid-Rectal Cancer, Rectal Cancer Stage II | Status: NOT_YET_RECRUITING